PAM
FOMX

Panagora Asset Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Panagora Asset Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-24,814
Closed -$230K – 2495
2015
Q1 		$230K Buy
+24,814
New +$222K ﹤0.01% 1623

Other funds holding FOMX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Panagora Asset Management's FOMX Position: Q2 2015 in Review

Panagora Asset Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2015, closing a stake of 24,814 shares — an estimated $230K sold.

Panagora Asset Management first reported a position in FOMX in Q1 2015 and held it in 1 quarter. The position peaked at $230K in Q1 2015. 84 funds tracked by Wall St. Rank hold FOMX as of Q2 2015.

  • Panagora Asset Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2015 after selling out during the quarter.
  • Panagora Asset Management sold 24,814 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2015, an estimated $230K.
  • Panagora Asset Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2015 and held it in 1 quarter.
  • Panagora Asset Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $230K in Q1 2015.
  • 84 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2015.

Based on Panagora Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.